JAPER
× About the Journal Scope of the Journal SPER Publications Editorial Board Abstracting and Indexing Articles in Press Current Issue Archives Conference Proceedings Submit Article Author Guidelines Advertise Join as Reviewer Contact Publishing Ethics


 
Year : 2014   |  Volume : 4  |  Issue : 1  |  Page : 75-79

Comparative and Optimization of administration of Dexlansorazole through nasogastric tubes using an oral liquid vehicle as a suspending agent
Proton pump inhibitors (PPIs) are widely used for the treatment of various acidrelated disorders. For intensive care patients Stress-induced gastrointestinal tract bleeding (SGIB) is common, Dexlansoprazole is a PPI that suppresses gastric acid secretion by specific inhibition of the (H+ ,K+ )-ATPase in the gastric parietal cell. The aim of this study was to compare the behavior of the dexlansoprazole during the transit of the pellets through the nasogastric tube and to optimize the mode of administration. In this experiment we designed to study the influence of four variables: the tube material (silicone or polyurethane), the solvent used to disperse the pellets (water or apple juice), the mode of administration and the rinse volume . We counted the pellets before administration to tube and at the tube outlet, and assayed the dexlansoprazole by UV spectrometry. The assay showed that transit of dexlansoprazole through the tube, was nearly 85.5 to 99.6%. There is asignificant improvement was obtained by the variables ‘diluent’ and ‘mode of administration’. The variable ‘rinse’ had a significant influence. Dexlansoprazole is thus the choice of Proton pump inhibitor for the treatment of patients by nasogastric tube, using a polyurethane tube and a rinse 10 ml of apple juice.
[PDF]*
Print this article     Email this article

 

Contact SPER Publications


SPER Publications and Solutions Pvt. Ltd.

HD - 236,
Near The Shri Ram Millenium School,
Sector 135,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India
Phone: +91-9301907999 / +91-8400033397
E-mail: journals@sperpublications.com
Website: www.sperpublications.com